Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury
Physiological Reports · 2026-06 · 14 (11)
DOI: 10.14814/phy2.70942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 29.05.2026. Verfasst von Madison McGraw und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. Hauptthemen laut MEDLINE: Receptor, Anaphylatoxin C5a, Reperfusion Injury, Mitochondria, Kidney. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, American Heart Association (AHA), National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Ischemia‐reperfusion injury (IRI) is a prevalent condition that predominantly afflicts hospitalized patients, inducing acute kidney injury (AKI). In recent years, complement 5 (C5) and its anaphylatoxin receptor C5aR1 have been implicated in driving kidney IRI and loss of function. Beyond this, prior studies suggest C5‐C5aR1 mediates mitochondrial ROS production, although its role in the mitochondria has never been fully characterized. Here, we leverage a previously generated model of C5 gene deletion (male C5 −/− rats) and the clinically relevant C5aR1 inhibitor Avacopan (AV) to investigate C5‐C5aR1 signaling in renal mitochondrial physiology and pathophysiology. For the first time, we report that C5‐C5aR1 axis inhibition modifies physiological mitochondrial protein levels, respiratory activity, and complexes/supercomplexes. We identified a novel relationship between the C5‐C5aR1 axis and ATPase Inhibitory Factor 1 (IF1), a potent regulator of the ATP synthase, using in vivo and in vitro approaches. Post‐IRI, C5‐C5aR1 axis inhibition improved kidney function/morphology and preserved ATP levels, despite IRI‐mediated disintegration of mitochondrial complexes and supercomplexes. We show in vitro that C5‐C5aR1 axis inhibition facilitated IF1‐dependent ATP recovery via the glycolysis pathway. Collectively, our results demonstrate a complex interplay between C5‐C5aR1 and IF1 in renal mitochondria, which contributes to mitochondrial pathophysiology during IRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
ORCID-Profile: Madison McGraw, Nirmala Parajuli
Förderung
- NIDDK NIH HHS
- American Heart Association (AHA)
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
McGraw, M., Sharma, A., Bhattarai, D., Gokden, N., Macmillan-Crow, L., & Parajuli, N. (2026). Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury. Physiological Reports, 14(11). https://doi.org/10.14814/phy2.70942
Vancouver
McGraw M, Sharma A, Bhattarai D, Gokden N, Macmillan-Crow L, Parajuli N. Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury. Physiological Reports. 2026;14(11). doi:10.14814/phy2.70942
BibTeX
@article{McGraw2026,
author = {McGraw, Madison and Sharma, Amod and Bhattarai, Dinesh and Gokden, Neriman and Macmillan-Crow, LeeAnn and Parajuli, Nirmala},
title = {Novel interactions between the C5 ‐ C5aR 1 Axis and IF 1: Implications for kidney mitochondrial physiology and ischemia–reperfusion injury},
journal = {Physiological Reports},
year = {2026},
volume = {14},
number = {11},
doi = {10.14814/phy2.70942}
}
EUVIMED